Zhejiang, China

Hancheng Zhang

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Hancheng Zhang: Innovator in Pharmaceutical Chemistry

Introduction

Hancheng Zhang is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on developing innovative compounds that have the potential to treat various diseases, including cancers.

Latest Patents

Among his latest patents, Hancheng Zhang has developed a heterocyclic compound that acts as a CDK-HDAC double-channel inhibitor. This invention provides compounds of formula (I), including their possible enantiomers and diastereomers, as well as pharmaceutically acceptable salts, hydrates, or solvates thereof. Additionally, the invention offers pharmaceutical compositions of these compounds, methods for their preparation, and their use in treating diseases and disorders, particularly cancers. Another notable patent is a heterocyclic compound that serves as a CDK-HDAC dual pathway inhibitor, which similarly provides compounds of formula (I) and their pharmaceutical applications.

Career Highlights

Hancheng Zhang is currently associated with Hangzhou Innogate Pharma Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His innovative work has garnered attention in the scientific community, contributing to advancements in cancer treatment.

Collaborations

Hancheng Zhang collaborates with esteemed colleagues, including Shifeng Liu and Xiangyang Ye, to further enhance the impact of his research and inventions.

Conclusion

Hancheng Zhang's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing effective treatments for serious health conditions. His ongoing work and patents reflect a commitment to improving patient outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…